Shanghai Ruikang Biotechnology has established research and development centers and subsidiaries in multiple locations including Shanghai, Tianjin, and Silicon Valley in the United States. Adhering to independent research and innovation, it has established a full range of technology development platforms for biochemical reagents, clinical mass spectrometry, third-party quality control products, etc., providing compliant, standardized, and automated products for clinical testing and quality control, Especially, mass spectrometry technology provides a comprehensive solution for IVD products in clinical precision diagnosis and treatment applications, covering the entire business process. Business scope covers medical institutions CDC、 We are committed to the sustainable development of human health and the medical industry through third-party testing institutions, international cooperation, and the exploration of international markets!